Antares Pharma is a revenue-generating product-focused specialty pharmaceutical company that has developed three proprietary platforms, two of which now include FDA-approved products. Its products typically improve safety and efficacy profiles by minimizing dosing and reducing side effects while improving patient compliance. It focuses on self-injection pharmaceutical products and technologies and topical gel-based products. Its subcutaneous injection technology platforms include Vibex disposable pressure-assisted auto-injectors, Vision reusable needle-free injectors, and disposable multi-use pen injectors.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Antares Pharma Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Antares Pharma Inc market cap is $955.06M.
What is the 52-week high for Antares Pharma Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Antares Pharma Inc 52 week high is $5.60 as of September 28, 2025.
What is the 52-week low for Antares Pharma Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Antares Pharma Inc 52 week low is $3.11 as of September 28, 2025.
What is Antares Pharma Inc stock price today?
Antares Pharma Inc stock price today is $5.59.
What was Antares Pharma Inc stock price yesterday?
Antares Pharma Inc stock price yesterday was $5.59.
What is the PE ratio of Antares Pharma Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Antares Pharma Inc’s P/E ratio is 24.28.
What is the Price-to-Book ratio of Antares Pharma Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Antares Pharma Inc P/B ratio is 5.4250.
What is the 50-day moving average of Antares Pharma Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Antares Pharma Inc 50-day moving average is $4.90.
